Drug Profile
NKF 202
Alternative Names: NKF-202Latest Information Update: 05 Sep 2018
Price :
$50
*
At a glance
- Originator PUMC Pharmaceutical Company
- Class Vitamin D analogues
- Mechanism of Action Vitamin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Vitamin D deficiency
Most Recent Events
- 05 Sep 2018 No development reported - Preregistration for Vitamin D deficiency in China (PO)
- 26 Nov 2015 Preregistration for Vitamin D deficiency in China (PO)